News | January 05, 2010

FDA Says RFID Devices Cause Malfunctions in Pacemakers, ICDs

January 6, 2010 – The FDA, in collaboration with major implantable pacemaker and implantable cardioverter-defibrillator (ICD) manufacturers, demonstrated the effects of emissions from radio frequency identification (RFID) readers on common implantable cardiac devices. According to research published in the January edition of the HeartRhythm Journal, the effects may cause increasing complications as RFID use expands in the medical device field.

The study, which looked at the electromagnetic interference susceptibility of 15 pacemakers and 15 ICDs caused by exposure to 13 RFID readers, concluded that low frequency RFID readers may pose the greatest risk to pacemakers and ICDs. While modern pacemakers and ICDs use filters to minimize susceptibility to higher-frequency signals, there is limited filtering of low frequency signals due to the design constraints of both pacemakers and ICDs.

The in vitro testing concluded that low frequency RFID readers caused reactions in 67 percent of pacemaker and 47 percent of ICD tests. During tests at multiple separation distances between RFID reader and the implanted device, ranging from 2.5 to 60 cm, the RFID readers’ emissions creating the most interference were recorded at the shortest distance where the exposure is highest. The study indicates that for most practical exposure situations a minimum separation distance of 2.5 cm may not be possible; however, there are medical applications where 2.5 cm separation distance is feasible.

“We do not believe the current situation reveals an urgent public health risk,” said lead author Seth J. Seidman, research electrical engineer for the FDA’s Center for Devices of Radiological Health. “However, we are concerned that the continued proliferation of RFID without taking electromagnetic interference into consideration could cause clinically significant events for patients.”

Among the reactions from pacemakers and ICDs includes pacing inhibition, inappropriate pacing, noise reversion mode, changed pacing rates, inappropriate delivery of anti-tachycardia pacing, inappropriate high-voltage shocks and device programming change. Although in vitro testing demonstrated the potential for pacemaker and ICD interference, the FDA has not received any incident reports of electromagnetic interference caused by any RFID system.

Seidman said while clinical exposure to RFID readers is uncommon, advances in medical applications using RFID may lead to increased use in patient care. To mitigate pacemaker and ICD electromagnetic interference from RFID readers, implant manufacturers and the RFID industry must work to develop industry requirements and design future devices appropriately.

For more information: www.heartrhythmjournal.com

Related Content

Videos | Pacemakers | February 13, 2020
This video illustrates how the Micra AV leadless pacemaker is delivered via catheter and enables atrioventricular (AV
The Micra AV leadless pacemaker
News | Pacemakers | February 13, 2020
February 13, 2020 — The U.S.
Results from the MARVEL 2 (Micra Atrial Tracking Using A Ventricular accELerometer) study shows that an investigational set of algorithms in the Medtronic Micra Transcatheter Pacing System (TPS) significantly improves synchrony and cardiac function in patients with atrioventricular (AV) block. This is an impaired electrical conduction between the chambers of the heart.
News | Pacemakers | November 15, 2019
(February 2020 update — the results of this trial led to the FDA clearnace of the Micra AV device in January 2020
Co-principal investigator professor Aydin Babakhani at the UCLA Integrated Sensor Laboratory holds an earlier version of the prototype leadless, wireless amnd batteryless pacemaker. Photo Credit: Cody Duty, Texas Medical Center.

Co-principal investigator professor Aydin Babakhani at the UCLA Integrated Sensor Laboratory holds an earlier version of the prototype leadless, wireless and battery-less pacemaker. Photo Credit: Cody Duty, Texas Medical Center.

News | Pacemakers | November 13, 2019
FDA Warns of Premature Battery Depletion in Some Medtronic Pacemakers
News | Pacemakers | May 07, 2019 | Dave Fornell, Editor
The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare providers and patients...
Artificial Intelligence Can Improve Emergency X-ray Identification of Pacemakers
News | Pacemakers | March 29, 2019
A research team from Imperial College London believes a new software could speed up the diagnosis and treatment of...
Medtronic Recalls Dual Chamber Pacemakers
News | Pacemakers | February 20, 2019
Medtronic is recalling its dual chamber implantable pulse generators (IPGs) due to the possibility of a software error...
CHLA/USC Team Designs Novel Micropacemaker

Model of the human heart with microprocessor located in the pericardial sac and attached to the left ventricle. Graphic courtesy of Business Wire.

News | Pacemakers | June 29, 2018
Investigators at Children's Hospital Los Angeles (CHLA) and the University of Southern California (USC) have...
Permanent Pacing Effective for Older Patients With Syncope and Bifascicular Block
News | Pacemakers | May 24, 2018
Syncope with bifascicular block may be caused by intermittent complete heart block, but competing diagnoses may coexist...
Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System Detects Atrial Contractions, Restores AV Synchrony
News | Pacemakers | May 24, 2018
New clinical study results demonstrate that an investigational algorithm, utilizing the accelerometer signal in the...